Decisions a C-Suite would make for Life Sciences & Biotech Consulting
Vendor comparisons that are honest about where each tool falls short, plus a plan for doing the work yourself. Where we quote a benchmark, we show its source.
15 guides for Life Sciences & Biotech Consulting of 1,000
Financing a Biotech Consultancy Through Sponsor Funding Gaps
Life sciences sponsors pause programs between funding rounds, so a signed statement of work can become a hold. Here's how to finance a consultancy through it.
Ironclad vs LinkSquares for Biotech Consultants: CDAs and MTAs
For life sciences and biotech consultants, how Ironclad and LinkSquares compare for confidentiality agreements, material transfer terms, and IP.
Board Pitfalls for Life Sciences Consulting Firms
Life sciences and biotech consulting firms face client conflicts and confidentiality risks most professional services boards don't. Five pitfalls to avoid.
Bizee vs. Doola for Life Sciences Consultants: Entity Setup
Forming a life sciences or biotech consulting practice: trade secret handling, regulatory-adjacent advice, liability coverage, and Bizee vs. Doola compared.
Vouch vs Embroker for Life Sciences and Biotech Consulting Firms
Two ways a life sciences or biotech consulting firm can approach Vouch and Embroker for E&O, cyber, and regulatory advisory risk.
Mercury vs Relay: Banking for a Life Sciences Consultancy
Life sciences and biotech consultancies often run grant-funded and milestone-funded work with long cash cycles. Compare Mercury and Relay for that pattern.
Equity, IP, and Conflicts of Interest at a Biotech Consultancy
Biotech and life sciences consultancies face conflict-of-interest and IP ownership questions before they ever get to picking Pulley or Carta.
Deel vs Remote for Biotech Consulting: Who Owns the Invention
Why invention assignment, not onboarding speed, should decide Deel vs Remote for life sciences and biotech consulting firms hiring scientific staff abroad.
PEO Options for a Life Sciences Consulting Firm
Life sciences and biotech consultancies mix PhD-heavy desk staff with lab-based work. Here's how Justworks and TriNet fit that combination.
Biotech Consulting: A Pitfalls Checklist for Grant-Funded Work
Grant funding and private engagements carry different accounting rules. A pitfalls checklist for the fractional CFO vs controller call at a biotech consultancy.
Financing a Life Sciences Consultancy Around Grant-Funded Clients
Life sciences and biotech consultancies often bill clients whose own funding is grant-based, which changes typical cash timing. Here's how to plan around it.
Carta vs Forge For A Life Sciences Consulting Firm
IP sensitivity and foreign-investment review change how a life sciences or biotech consulting firm should weigh Carta against Forge for equity liquidity.
Filling a VP of Regulatory Affairs at a Biotech Consultancy
A step-by-step approach for a life sciences or biotech consulting firm choosing between a search firm and an executive marketplace.
A Checklist for Selling a Life Sciences Consulting Firm
What life sciences and biotech consulting firm owners should check before listing on Acquire.com or Flippa, from IP ownership to client concentration.
Optery vs DeleteMe for Biotech Consulting Leaders
A pitfalls-first checklist for life sciences and biotech consulting leaders comparing Optery's automated removal to DeleteMe's human-run service.